Together, CD44 down-regulation and E-cadherin overexpression indicate Sal-Doc SE-NP could inhibit CSCs or induce CSCs transforming, which is one key target for suppression of cervical tumor progression. This evidence concerns the gene CDH1 and uterine cervix neoplasm.